U.S. Reports 156K New Covid Cases, 418 Deaths

uscoronavirus july26 lt

With 156,904 new cases reported on Monday, the total number of people that have been infected the with coronavirus in the United States has risen to 90,570,695, as per Johns Hopkins University's latest data.

418 additional deaths on the same day took total U.S. Covid casualties to 1,027,373.

Florida reported the most number of new cases - 27,045 - and deaths - 175.

Covid deaths have increased by 34 percent and cases have increased by 10 percent in the last two weeks, New York Times' latest tally shows.

Nearly 43,000 people are currently in American hospitals with the coronavirus, an increase of 12 percent over the last two weeks. More than 4,800 of these patients are admitted in intensive care units, marking a 12 percent rise in a fortnight.

87,549,615 people have so far recovered from the disease, the Worldometer tally shows.

1,899 additional deaths were reported globally on Monday, taking the total number of people who lost their lives due to the pandemic so far to 6,386,517.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22. ANI Pharmaceuticals, Inc. (ANIP) Monday announced a wider loss for the second quarter, despite a 52 percent surge in revenues. For the full year 2022, the company reiterated the adjusted earnings per share range, revenue guidance and raised Cortrophin revenue outlook. The company reported a quarterly... Shares of BioNTech SE were losing around 4 percent in the morning trading in Germany and around 5 percent in the pre-market activity on Nasdaq after the German Covid-19 vaccine maker reported sharp drop in profit and revenues for the second quarter. However, the company recorded strong growth in first-half results. Further, the company maintained BioNTech COVID-19 vaccine revenue guidance
Follow RTT